D
Definitive Healthcare Corp
NASDAQ:DH
Definitive Healthcare Corp
NASDAQ:DH
Price:
6.73 USD
-7.17%
Market Closed
Updated:
Apr 27, 2024
Section:
Relative Value
The Relative Value of one DH stock under the Base Case scenario is 10.01 USD. Compared to the current market price of 6.73 USD, Definitive Healthcare Corp is Undervalued by 33%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
DH
Relative Value
Base Case
10.01
USD
Undervaluation 33%
D
Valuation Multiples
Multiples Across Competitors
DH Competitors Multiples
Definitive Healthcare Corp Competitors
Definitive Healthcare Corp Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
D
|
Definitive Healthcare Corp
NASDAQ:DH
|
792.3m USD | 3.2 | -3.9 | 34.9 | -23.5 | |
| US |
|
Veeva Systems Inc
NYSE:VEEV
|
32.4B USD | 13.7 | 61.7 | 61.5 | 66.2 | |
| US |
|
Cerner Corp
NASDAQ:CERN
|
27.9B USD | 4.8 | 47.3 | 19.6 | 38.6 | |
| US |
|
Change Healthcare Inc
NASDAQ:CHNG
|
9B USD | 2.6 | -116.8 | 16.5 | 111.6 | |
| JP |
|
M3 Inc
TSE:2413
|
1.3T JPY | 5.4 | 27.5 | 14.6 | 16.4 | |
| AU |
|
Pro Medicus Ltd
ASX:PME
|
11.4B AUD | 78.1 | 163.9 | 112.7 | 112.7 | |
| US |
|
Inspire Medical Systems Inc
NYSE:INSP
|
7.1B USD | 11.4 | -337.9 | -178.7 | -166 | |
| US |
|
Doximity Inc
NYSE:DOCS
|
4.5B USD | 9.6 | 32.5 | 21.8 | 23.2 | |
| SE |
|
Sectra AB
STO:SECT B
|
41.8B SEK | 25.5 | 98.5 | -64.8 | -64.8 | |
| US |
|
Evolent Health Inc
NYSE:EVH
|
3.2B USD | 1.6 | -22.7 | 26.6 | 283.6 | |
| US |
|
Goodrx Holdings Inc
NASDAQ:GDRX
|
2.9B USD | 3.8 | -323.5 | 34.5 | -112.7 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
You don't have any saved screeners yet
